Immunogenicity of engineered antibodies
Top Cited Papers
- 12 April 2005
- Vol. 36 (1), 3-10
- https://doi.org/10.1016/j.ymeth.2005.01.001
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Cellular and humoral responses after multiple injections of unconjugated chimeric monoclonal antibody MOv18 in ovarian cancer patients: a pilot studyZeitschrift für Krebsforschung und Klinische Onkologie, 2002
- Phase I Clinical Evaluation of a Neutralizing Monoclonal Antibody against Epidermal Growth Factor ReceptorCancer Biotherapy & Radiopharmaceuticals, 2001
- Preoperative Clinical Radioimmunodetection of Pancreatic Cancer by111In-labeled Chimeric Monoclonal Antibody Nd2Japanese Journal of Cancer Research, 1999
- A phase I study of human/mouse chimeric antiganglioside GD2 antibody ch14.18 in patients with neuroblastomaEuropean Journal Of Cancer, 1995
- Human anti-mouse antibody response to the injection of murine monoclonal antibodies against IL-6Clinical and Experimental Immunology, 1994
- PREVENTION OF ADVERSE CLINICAL OUTCOME BY MONITORING OF CARDIAC TRANSPLANT PATIENTS FOR MURINE MONOCLONAL CD3 ANTIBODY (OKT3) SENSITIZATIONTransplantation, 1993
- Current status of cancer immunodetection with radiolabeled human monoclonal antibodiesSeminars in Nuclear Medicine, 1993
- Indium-111 monoclonal antibody b72.3 scintigraphy in colorectal cancer correlation with computed tomography, surgery, histopathology, immunohistology, and human immune responseCancer, 1992
- Human anti-mouse antibody response induced by anti-CD4 monoclonal antibody therapy in patients with rheumatoid arthritisClinical Immunology and Immunopathology, 1991
- Sequential Use of lndium-111 Labeled Monoclonal Antibodies 96.5 and ZME-018 does not Increase Detection Sensitivity for Metastatic MelanomaClinical Nuclear Medicine, 1989